First Growth Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Sell
509
-39
-7% -$39.8K 0.46% 62
2026
Q1
$523K Sell
548
-7
-1% -$7.1K 0.47% 64
2025
Q4
$564K Buy
+555
New +$531K 0.5% 52

Other funds holding LLY

First Growth Capital's LLY Position: Q2 2026 in Review

First Growth Capital reduced its Eli Lilly (LLY) stake by 7.1% in Q2 2026, selling an estimated $39.8K and leaving 509 shares worth $611K. The position accounts for 0.46% of the portfolio, ranked #62.

First Growth Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Growth Capital held 509 shares of Eli Lilly worth $611K as of Q2 2026.
  • First Growth Capital sold 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.46% of First Growth Capital's portfolio in Q2 2026, its #62 holding.
  • First Growth Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Growth Capital's 13F filing for Q2 2026, filed 16 Jul 2026.